Category: News

The Austrian Academy of Physicians celebrated its 25th anniversary in October 2025 with a conference. In 1995, the Diploma Continuing Education Program was established under the auspices of the Austrian Medical Association to create a uniform framework for the continuing education and training of physicians. Since 2014, physicians have been required to provide evidence of 250 continuing education units (= 250 diploma continuing education points) every five years. The DFP thus became the quality assurance standard for continuing medical education. This program also ensures that courses are quality-assured and transparently documented.
At a conference in Vienna in October, the most important milestones and the growing significance of the Academy of Physicians for the Austrian medical profession were presented. In addition, the founding members of the Academy of Physicians were thanked with certificates of honor.
Among them was Univ.-Prof. Dr. Heinrich Klech, Managing Director of the Vienna School of Clinical Research, Public Health and Medical Education (VSCR), who co-founded the Academy of Physicians after many years as continuing education officer of the Austrian Medical Association.
Since the Academy of Physicians was founded, the VSCR has been a reliable partner for accreditations and also contributes to the success of the Academy of Physicians’ DFP program with its own continuing education events.

Photo: “Austrian Academy of Physicians / Stefan Seelig”
People from left to right
Prof. Manfred Dierich, emeritus director, Institute for Hygiene and Microbiology Innsbruck, founding member of the Academy
Prof. Heinrich Klech, managing director, VSCR, Vienna, founding member of the Academy
Prof. Heinrich Weber, emeritus director of cardiology, Donauspital SMZ Ost, Vienna, founding member of the Academy
Dr. Peter Niedermoser, President of the Scientific Advisory Board of the Academy of Physicians
Dr. Wolfgang Routil, Founding Member, President of the Academy of Physicians from 2000 to 2012
Mag. Günther Ochs, Managing Director of the Academy of Physicians

Dear friends and supporters of VSCR,
2024 was a challenging, but a successful year of performance. It brought new projects and new geographic extensions.

MAIN ACTIVITIES

In 2024, VSCR and its faculty were engaged in several Capacity Building Programs for public and institutional health policy makers/payers from various geographies. These accredited programs were designed and led by Prof. Lieven Annemans, MSc, PhD, Senior Professor of Health Economics, Ghent University, Belgium and Prof. Heinrich Klech, MD, PhD, Managing Director VSCR, Vienna and Margarete Schreiner-Karner, MSc, Operational Manager VSCR.

CAPACITY BUILDING PROGRAM IN GCC COUNTRIES

In 2024, a large number of policy makers and payers from GCC countries (UAE, Qatar, Kuwait, Oman, Bahrain) successfully have accomplished VSCR’s Diploma Programs in Health Outcome Research (HEOR) and HTA Technology.
This program was executed in cooperation with EHES (Emirates Health Economic Society) and I&S (Ideas and Solutions, Hungary). The modules were executed in a hybrid fashion (online and onsite in Dubai). We thank Dr. Sara Al Dallal, President of Emirates Health Economics Society as well as Prof. Lieven Annemans and the directors of Ideas &Solutions, Inc., Dr. David Danko and Dr. Mark Molnar for their excellent contributions. This program was supported by an unrestricted grant from Johnson & Johnson.

VSCR and Ideas & Solutions in Dubai

CAPACITY BUILDING PROGRAM IN SUB-SAHARAN AFRICA

Currently a large number of health policy makers/payers from Sub-Saharan Africa (SSA) including countries such as Ghana, Nigeria, Ivory Coast, Cameroon, Senegal, Namibia, Botswana, Kenya, Rwanda have started VSCR’s HEOR Diploma together with an informal training about Supply Chain Technology and Health Systems Awareness, Resilience and Transformation. This program will continue until the end of 2025.

Prof. Lieven Anneman and VSCR in virtual ZOOM Meetings with delegates from Sub-Saharan Africa

Experts such as Prof. Lieven Annemanns, University of Ghent, Belgium and Prof. Justice Nonvignon, Public Health, University of Ghana, both distinguished members of VSCR’s faculty presented valuable business cases and examples. Further experts were Nina Bressler, Head of Societal Learning, Novartis Institute and many more. This VSCR Diploma Program was supported by an unrestricted grant from Novartis.

Selected European stakeholders attended successfully VSCR’s regular HEOR Diploma programs in 2023 and 2024. Partly supported by Eli Lilly, Indianapolis, USA.

FURTHER ACTIVITIES OF VSCR IN 2024

DIGITAL MARKETING TRAINING

April 2024: Digital Marketing Training for employees of STADA in UAE- (executed in Prague by Margarete Schreiner-Karner, MSc, Operational Manager VSCR and Thomas Catulli, CEO of SPS Marketing, Digital Marketing Agency

Margarete Schreiner-Karner and Thomas Catulli with STADA UAE in Prague, April 2024

September 2024: HEOR Diploma training for leaders of dialysis centers in Algeria. The Diploma modules were produced and led by Dr. Jürgen Raths, Switzerland, Senior lecturer HEOR of VSCR and executed in Sharm El Sheik, Egypt. This program was supported by an unrestricted grant from Julphar Pharma, Algeria

Dr. Jürgen Raths, Managing Director Cordée Consulting in Sharm El Sheik, November 2024

GROWTH IN MEDICAL AFFAIRS AND MEDICINES DEVELOPMENT

VSCR and IMPACT in UAE started in October 2024 with the first virtual modular educational program about “Creating a high-performance organization in Medical Affairs and Medicines Development in Saudi Arabia” and finalized in December 2024 with Oncology and Real-World Evidence, and its importance in the corresponding studies.
Speaker:
Module 1: Growth in Medical Liaison Management – Role of MSLs: Margarete Schreiner-Karner, MSc
Module 2 and 3: Conducting Clinical Research and Clinical Trial Design: Prof. Heinrich Klech
Module 4: Exploration of Studies in Oncology and Real – World Data:
The Clinical trialist´s perspective: Prof. Michael Gnant, MD, PhD, ABCSG
Introduction to Real-World Evidence and Statistical aspects of example trials:
Dr. Maximilian Pilz, Novustat GmbH

MSL – Module 1 and 2:

Margarete Schreiner-Karner, MSc and Prof. Heinrich Klech, MD, PhD, FCCP, GFMD

Module 3 and 4:

Prof. Michael Gnant, ABCSG and Dr. Maximilian Pilz, Novustat GmbH

We thank Prof. Michael Gnant, MD, PhD, Medical University Vienna, President of Austrian Breast and Colorectal Cancer Study Group (ABCSG) for giving great insights into today’s concepts in oncology as well as Dr. Maximilian Pilz of NOVUSTAT GmbH, Germany for excellent presentations about medical statistics.

Many thanks to our business partners in Middle East, Mr. Magdy Abuelfadl, BPharm (Impact), Mr. Mohamed Fahmy, BPharm (Headway) and to our Sponsor Johnson & Johnson Innovative Medicines in Saudi Arabia.

Mr. Mohamed Fahmy, BPharm (Headway, UAE) and Mr. Magdy Abuelfadl, BPharm(Impact), UAE,

DIPLOMA ADVANCED TRAINING with Austrian Medical ASSOCIATION

Continuous scientific recognitions/accreditations of CPD (Continuous Professional Development) modules/meetings from selected professional scientific providers (e.g Medahead and MedMedia, both in Vienna) for the CPD program (DFP- Diplom -Fortbildungs Program) of the Austrian Medical Association (Österr. Äztekammer)

OUTLOOK2025

Building a network-payer academy in Sub-Saharan Africa
Academic course in Pharmaceutical Policy & Governance for JENA and Saudi Arabia (in cooperation with Ideas and Solutions, Hungary)

Finally, we want to thank all VSCR faculty members for their great contributions as well as all the supporters and sponsors from industry.
Thanks to the Sigmund Freud University Vienna for additional accreditation of some of our programs.
Also, a special thanks to Mr. Mohamed Fahmy, BPharm, Managing Director of Headway, UAE for his partnership and support for projects in Middle East and Africa.

VSCR is pleased to have successfully completed the 4th ONLINE module of the Medical Affairs training for Saudi Arabia.
We are very proud that we could win Prof. Michael Gnant, oncology expert and surgeon from Austria and Dr. Maximilian Pilz, biostatistical expert from Germany to do study explorations from a clinical and statistical point of view. Our best wishes and good luck for 2025 to the Medical Liaison Managers in Saudi Arabia.
Many thanks to the sponsor J&J and our business partners Mr. Magdy Abuelfadl from Impact and Mr. Mohamed Fahmy from Headway in UAE.

Univ. Prof. Dr. Michael Gnant, Austria

We are happy to announce VSCR´s recent virtual modular educational program about “Creating a high – performance organization in Medical Affairs and Medicines Development”.
VSCR and IMPACT started in October 2024 with the first module about Growth of Medica Liaison Managers in the respective region Saudi Arabia and will close in December with Real World Evidence, its importance and the corresponding studies.
Many thanks to our business partners in Middle East, Mr. Magdy Abuelfadl (Impact), Mr. Mohamed Fahmy (Headway) and to our Sponsor Johnson & Johnson Innovative Medicines in Saudi Arabia.
Looking forward to the upcoming modules with our appreciated stakeholders.
Lectures:
CREATING A HIGH-PERFORMANCE ORGANIZATION IN MEDICAL AFFAIRS AND MEDICINES DEVELOPMENT for SAUDI-ARABIA

Speaker Module 1: ROLE of Medical Liaison Managers; Margarete Schreiner-Karner, MSc, VSCR

Speaker Module 2-4: Clinical Research; Prof. Heinrich Klech, VSCR

Speaker Module 2-4: Biostatistics; Dr. Maximilian Pilz, NOVUSTAT Statistics Services (Germany)

VSCR and its faculty are increasingly engaged in Capacity Building Programs for public and institutional health policy makers/payers from various geographies.
In 2024 a large number of policy makers and payers from GCC countries (United Arab Emirates, Qatar, Kuwait, Oman, Bahrain) successfully have accomplished VSCR´s Diploma Programs in Health Outcome Research (HEOR) and HTA Technology. This program was executed in cooperation with EHES (Emirates Health Economic Society) and I&S (Ideas and Solutions, Hungary).
Currently a large number of health policy makers/payers from Sub-Saharan Africa (SSA) including countries such as Ghana, Nigeria, Ivory Coast, Cameroon, Senegal, Namibia, Botswana, Kenya, Rwanda have started VSCR’s HEOR Diploma This SSA program will continue until the end of 2025.
Selected European stakeholders attended successfully VSCR´s HEOR Diploma programs in 2023 and 2024. The programs are designed and led by Prof. Lieven Annemans, MSc, PhD, Senior Professor of Health Economics, Ghent University, Belgium and Prof. Heinrich Klech, MD, PhD, Managing Director VSCR and Margarete Schreiner-Karner, MSc, Operational Manager VSCR.
VSCR is partner and supporter of PharmaTrain and IFAPP.

VSCR´s Diploma Program in Dubai for GCC health policy makers

VSCR´s Payer Capability Program for health policy makers in Sub-Saharan Africa

VSCR and its faculty have increasingly been engaged in Capacity Building Programs for public and institutional health policy makers/payers in various geographies:
Currently a large number of health policy makers/payers from Sub- Saharan Africa (SSA) including countries such as Ghana, Nigeria, Ivory Coast, Cameroon, Senegal, Namibia, Botswana, Kenya, Rwanda have started VSCR´s HEOR 1 year – Payer´s Capability program (PCBP).
This program is ONLINE. Next module 5 dealing with Real World Data will take place on 5th September 2024. The scientific lead person of the program is Prof. Lieven Annemans, Senior Professor of Health Economy, University Ghent.
We look forward to welcome our appreciated key stakeholders from Sub-Saharan Africa within our next module on 5th September 2024 again.
Yours, Prof. Lieven Annemans, Mag. Margarete Schreiner-Karner and Prof. Heinrich Klech

Heinrich Klech, Managing director of VSCR is pleased to announce his chair during VSCR conference about Health Economy and HTA in Dubai together with Prof. Lieven Annemans, Ghent university, Belgium, and David Danko, Ideas & Solutions, Hungary, under the auspices and support of EHES (Emirates Health Economy Society) from 10-11 May 2024.
Key topics and discussions about: Opportunities and challenges for light and heavy HTA approaches in the Gulf region.

Prof. Heinrich Klech, VSCR; Prof. Lieven Annemans, Ghent University; Dr. David Danko, I&S

Prof. Heinrich Klech, VSCR;
Dr. Sara Al Dallal, President of Emirates Health Economics Society,
Prof. Lieven Annemans, Ghent University
Ceremony award

With pleasure I want to announce that Univ.-Prof. Dr. Bob Djavan, has joined the Educational Advisory Board of VSCR and has accepted the newly formed position as
Chair VSCR Committee International Relations.
In his new role, Prof. Djavan will further organize/intensify the international network of VSCR and will further contribute to new academic and business relationships in many parts of the world.
Bob Djavan is Professor of Urology Medical University Vienna (MUW) and New York University (NYU). Together with many other international leadership positions, he is the current Chairman of the Uroloy Center at Rudolfinerhaus, Vienna and Chairman of the GULF Uro-oncology Center in Bahrain. He is honorary Professor of the University of Budapest, Krakow, Bucharest and Pecs.
Prof. Djavan brings a wealth of academic and professional leadership experience from many parts of the world including academic fellowships in Dallas at University of Texas and John Hopkins School of Medicine, Baltimore. He served in numerous executive roles within international professional associations such as the European Association of Urology (EAU), the European Society of Oncological Urology, the WHO, the Vienna Urology Foundation, and many others. He is recipient of many national and international scientific awards as well as supporting grants both from academics and from industry. He is a well sought member of many international advisory boards both in academics as well as in industry. He serves on editorial boards and as reviewer of more than 10 international medical journals.
He was guest lecturer and congress chairman in numerous parts of the world.
Please join me in welcoming Prof. Djavan in his new role in VSCR.
Heinrich Klech, MD, PhD, FACP, GFMD
Professor of Internal Medicine,
Managing Director, VSCR

Univ.-Prof. Dr. Bob Djavan, Chairman of the Uroloy Center at Rudolfinerhaus, Chair VSCR Committee International Relations

VSCR is very pleased to inform about its latest in person training held for the STADA GCC team on 6 March 2024 in Prague.
Many thanks to our business partner, Mr. Mohamed Fahmy from Headway-me for giving us the opportunity to meet and work with such an inspiring marketing and sales team.
Lecturing in Digital marketing:
Thomas Catulli, Digital Marketing Expert, SPS-Marketing, Austria
Margarete Schreiner-Karner, Marketing, VSCR, Austria
Lecturing in Selling skills:
Dr. Laszlo Ling, International Consultant, Switzerland
Congratulations and continued success to this very talented and ambitious STADA team in the MENA region.

STADA GCC Digital Marketing Team

Margarete Schreiner-Karner, VSCR and Thomas Catulli, SPS Marketing, Austria

STADA GCC Sales Team

Dr. Laszlo Ling, International Consultant, Switzerland

VSCR participated in AFRICA DAY 2024 – Organized by the Austrian Federal Economic Chamber (WKÖ).
The event, a joint initiative of the Austrian Federal Ministry for Labor and Economy and the Austrian Federal Economic Chamber provided a platform for Austrian and African companies to connect.
It took place from January 30, 2024 until February 02, 2024.
Speaker Highlights on January 30, 2024:
Mrs. Carmen GOBY, Vice President Austrian Federal Economic Chamber
Mr. Martin KOCHER, Federal Minister of Labor and Economy (video message)
AND
His Excellency Nana Addo Dankwa AKUFO-ADDO, President of the Republic of Ghana
Motivational Keynotes were given by:
Mr. Didier Drogba: President at The Didier Drogba Foundation
Mrs. Nwabisa Mayema: Strategic Partnerships Director at Branson Centre of Entrepreneurship South Africa
See https://www.africa-day.at/

Margarete Schreiner-Karner, VSCR

AFRICA DAY 2024 by AUSSENWIRTSCHAFT Afrika/Nahost at WKO, Vienna, Austria, on Tuesday, January 30, 2024 – © MARKO’s PHOTOGRAPHY / www.marko.photo

On Friday, 12th January 2024, VSCR had the opportunity to follow interesting lectures concerning AI in Medicine. The event was organized by the Central European Cooperative Oncology Group (CECOG) in Vienna – lead by Univ. Prof. Dr. Christoph Zielinski.

Margarete Schreiner-Karner, VSCR

VSCR is thrilled to announce its first ONSITE training in DUBAI concerning Pharmaceutical Assessment, Pricing and Reimbursement Policy. This academic course for health care experts in the Gulf Cooperation Council (GCC) countries took place from 8th to 9th December 2023 in cooperation in with Emirates Health Economics Society (EHES). Delegates from the following countries participated in this course: UAE, Qatar, Oman, Kuwait, Bahrain.
Many thanks to our VSCR faculty:
Prof. Lieven Annemans, Senior Professor of Health Economics, Ghent University, Belgium; past president ISPOR. He was advisor to the Belgian Minister of Health, and president of the Flemish health council.
Prof. Heinrich Klech, Managing Director VSCR, Internal medicine specialist. Founder of VSCR, an international Center of Excellence for Clinical Research, Health Economy and accredited postgraduate medical education.
Dr. Dávid Dankó, Managing partner of Ideas & Solutions, Hungary, earned his degree in economics from Corvinus University of Budapest. He served as Deputy Director of Reimbursement at the Hungarian National Health Insurance Fund.
Dr. Márk Molnár, Managing partner of Ideas & Solutions, Hungary, and research fellow at the Corvinus University of Budapest. He earned his degree in medicine from Semmelweis University and in economics from the West–Hungarian University. He served as Director of Reimbursement at the Hungarian National Health Insurance Fund.

Prof. Lieven Annemans, Ghent University, Belgium

Dr. David Danko, Ideas & Solutions, Hungary

Dr. David Danko, Prof. Heinrich Klech, VSCR

VSCR is thrilled to announce its Health Outcome Research Diploma Program in Sub-Saharan Africa.
It will be provided ONLINE over one year to representatives of health care institutions coming from the following nine Sub-Saharan countries:
Kenya, Rwanda, Namibia, Botswana, Ghana, Nigeria, Senegal, Ivory coast and Cameroon.
Scientific Lead of the diploma program is Prof. Lieven Annemans, Senior Professor of Health Economy, Ghent University, Belgium and Guest Professor of VSCR.
Course directors are Prof. Heinrich Klech, Managing Director, VSCR and Margarete Schreiner-Karner, Operational Manager, VSCR.
We look forward to this exciting virtual journey in Sub-Saharan Africa throughout 2024.

Three giraffe on Kilimanjaro mount background in National park of Kenya, Africa

On 12 and 13 June 2023 VSCR provided a practice-oriented Good clinical practice course for Ludwig Boltzmann Institute for Lung health in Vienna.
Faculty:
Univ.-Prof. Dr. Heinrich Klech, MD, PhD, FCCP, GFMD, Professor of Medicine, Chief Executive Officer of Vienna School of Clinical Research (VSCR)
Dr. Ingrid Klingmann, MD, PhD, FFPM, FBCPM, GFMD, European Forum for Good Clinical Practice (EFGCP), PHARMAPLEX bvba
Mag. Dr. Dr. Prof. h.c. Alexander Hönel, Inspections and Auditor for GCP clinical trials
Our special thanks belong to
Prim.a Priv. Doz.in Dr.in Marie-Kathrin Breyer,
Head of the Department of Respiratory and Pulmonary Diseases at Clinic Penzing in Vienna
and Mag.a Alexa Kahraman, Team Lead and Study Coordinator at Clinic Penzing in Vienna who made this course happen.

Clinic Penzing, Vienna, June 2023

On May 9th 2023, VSCR took part in the first Austrian Life Science Day at Palais Niederösterreich in Vienna, organized by LISAvienna.
The focus was on lectures, discussions and networking with peers and key opinion leaders about rare disease and personalized medicine. The status quo and the future of precision medicine were examined from an academic, clinical and social perspective. Companies from Austria were presented and the challenges surrounding the clinical development of personalized therapies were examined from different perspectives.
The Austrian Life Science Day 2023 was organized by aws (priority program LISA) and FFG in cooperation with the Austrian Platform for Personalized Medicine (ÖPPM) and by LISAvienna. The host in Palais Niederösterreich was ecoplus, the business agency of the state of Lower Austria.

Margarete Schreiner-Karner, VSCR

SINCE 20 YEARS A LEADING LEARNING AND TRAINING ORGANIZATION FOR HEALTH OUTCOME RESEARCH, MARKET ACCESS AND HEALTH TECHNOLOGY ASSESSMENT (HTA)

This year VSCR celebrates its 20 years anniversary of providing courses and diploma in Health Outcome Research (HEOR) and Market Access (MA). Close to 1.000 participants from industry, academia and pharmaceutical policy organizations have attended our programs. Many of them have been awarded with our academic diploma jointly provided by the Sigmund Freud University and VSCR. Please join me in congratulating our VSCR faculty for their success. Attached find a brief document giving an overview about the last 20 years and highlighting the efforts and the legacy of our faculty and its diploma program in HEOR and MA.
Heinrich Klech, CEO VSCR
(March 2023)
Press release__290323

Interview with PHARMAustria and Univ.-Prof. Dr. Heinrich Klech

13 December 2022

Fact-based evaluation of health measures is THE key to market access for innovative medicines, Univ.-Prof. Dr Heinrich Klech, Managing Director of the Vienna School of Clinical Research, Public Health and Medical Education (VSCR), is convinced about this.

After his successful international academic career and positions in international R&D management, Univ.-Prof. Dr. Heinrich Klech, specialist in internal medicine and pneumology, founded the Vienna School of Clinical Research (VSCR) in 2000, an independent training center in close cooperation with the Medical University of Vienna and other international universities. Prof. Klech calls on all healthcare players to include health economics in their decisions. He tells more about this in an interview.

PHARMAustria: What is Health Outcome Research?

Univ.-Prof. Dr Heinrich Klech: Health Outcome Research (HEOR) is the systemic results research of health measures in patients and populations as well as with regard to the effects on a health system through a synthesis of medical and economic measurement and assessment parameters. The so-called pharmaco-economics is an essential part of this. The prerequisite for this is the systematic recording of medical patient data in the sense of evidence-based medicine with simultaneous knowledge of the costs and efficiency of a recorded healthcare system.

What can be achieved through HEOR?

Such data collection about the effects of health measures such as access to a new innovative drug is called a Health Technology Assessment (HTA). In addition to the known properties such as effectiveness and tolerability of a drug, this systematic scientific method also provides results on the efficiency and affordability of a new drug in a recorded healthcare system, enables health-economic comparisons to alternatives and thus helps with decisions about measures such as reimbursement or non-reimbursement a drug. Incidentally, there is an established and European networked HTA facility in Austria, the AIHTA (Austrian Institute for Health Technology Assessment), headed by Prof.in Dr.in Claudia Wild, with a focus on oncology and medical devices.

Why is such a systematic evaluation important?

HTA is now an indispensable piece of scientific knowledge, as it enables fact-based assessment of health interventions within modern healthcare systems.

Such measures can be, for example:

the decision to include a new, innovative drug in a health insurance provider’s catalog of services or, for example, only to provide it to a specific patient segment;

the decision to refund a new imaging method that can replace other methods and ultimately also makes economic sense.

HEOR and HTA integrate both medical and economic facts and enable a more holistic view of health measures and systems and therefore have a very important societal benefit and status. However, this is currently not sufficiently supported by the lack of transparency and availability of health data in Austria. In addition, the payers for medical services in this country are fragmented and often only have their own budget pots in view. However, I am hopeful that at least the linking and transparency of the data will improve in the next few years, because it is now clear to everyone involved that costs can be reduced and processes improved in this way.

What is the role of the VSCR?

As a center of excellence, the VSCR deals with the science of pharmaco-economics and has trained and trained over 2,000 scientists/students from over 40 countries with the help of an international faculty in the field of health and pharmaco-economics – since 2018 also in a joint international diploma program with the Sigmund Freud University in Vienna. In the diploma courses you receive the basic tools for the collection and interpretation of health economic data; workshops teach how an HTA dossier is put together and how negotiations with a wide variety of stakeholders can be optimized. The participants come mainly from industry. The VSCR diploma modules are aimed at market access specialists, country managers, key account managers, medical affairs and regulatory. There are also participants from university institutions as well as from health authorities and ministries. In addition, the VSCR, as a non-profit limited company, also organizes national and international courses as well as accredited training events for doctors.

Thank you for the interview!
MM-PharmAustria_4_22_Klech-Interview_englisch2

Source: « PHARMAustria | PA 04|2022 | Gesundheitsökonomie ist Trumpf!

https://www.medmedia.at/pharm-austria/gesundheitsoekonomie-ist-trumpf/

VSCR´s 2 days basic capabilities and training program for MARKET Access and Key Account Management

KEY Speaker: Prof. Lieven Annemans 16-17 January 2023

Value co-creation via Market Access and Key Account Management can be obtained via the use of five ad hoc “levers”: product performance; economic impact; institutional relationship; commercial organization; and communication which facilitate and promote the introduction, adoption and use of the product in the market and co-create value among the different stakeholders involved in the process. (Journal of Business & Industrial Marketing, Volume 36, Iss. 13 (2021):199–209)

See figure enclosed.

Thus, VSCR recommends a 2 days basic capabilities and training program

Target population: Key account managers, Medical, Regulatory, Product specialists, Country managers, Regional Sales managers, Medical science liaisons

For more information, please contact office@vscr.at

Vienna School of Clinical Research, Public Health and Medical Education supports Strategic Marketing Training in Lebanon, organized by Mr. Mohamed Fahmy, HeadWay DWC-LLC, Dubai.

Topic:

STRATEGIC THINKING & PLANNING: A Marketing Perspective

Lecturer: Mr. Magdy Abuelfadl, BSc, MBA

Lebanon, 7-9 November 2022

The best of luck and much success!

• Attend an exciting interactive workshop with Professor Lieven Annemans, University Ghent, Belgium, former ISPOR president
• Understand the importance of early health outcome evaluations to guide the development process
• Learn how the health economic and clinical evidence interact
• Learn about the dos and don’ts in outcome – based agreements

This Module is integral part of VSC`R`s Diploma program https://vscr.at/public-health/

However, this module is also open for other participants and can be registered and attended also individually. Program details: https://vscr.at/wp-content/uploads/HEOR_Module-III_Sept_STD_2022.pdf

In November 2018 the Vienna School of Clinical Research, Public Health and Medical Education (VSCR) agreed upon a cooperation with Sigmund Freud University of Vienna (SFU) to offer international Diploma courses for

• Health Economy
• Decision Making for Pricing and Reimbursement and
• HTA (Health Technology Assessment)

this program consists of three modules, each focusing on the knowledge and skills required for health outcomes research and health policy making.

It is designed and lectured by Prof. Lieven Annemans, Past President of ISPOR in cooperation with other members of the VSCR faculty.

Each of these modules are now awarded with a university certificate if successfully attended. In case of successful performance/attendance of all three modules an academic diploma – HEALTH OUTCOME – RESEARCH DIPOLMA – will be awarded jointly by the SFU and VSCR.

Each single module can be booked and attended individually. To subscribe to the 3-module diploma is not mandatory.

Since 2020 the modules will be entirely rolled out virtually (online). The course language is English.

MODULE I: Principles of Health Economics and Outcomes Research and Health Technology Assessment (HTA)

MODULE II: From outcome data to value dossiers: an introduction into the basics of successful HTA submissions

MODULE III: ELECTIVE MODULE- HOT TOPICS AND BUSINESS CASES AROUND HEOR AND HTA

The courses are intended for:

• Representatives of the pharmaceutical, biotech and medical technology industries,

like General Managers, Managers and Associates in Market Access and Marketing, Medical Affairs and Regulatory, Clinical development and Key Account Managers

• Members of registration authorities
• Payers (health insurances, policy makers)
• HTA organizations

On Sept 15th, 2022 Lieven Annemans for the first time will lead a practical workshop module “FROM TARGET PRODUCT PROFILE TO SUCCESSFUL PATIENT ACCESS.”

So far 189 students have attended VSCR- HEOR courses and 13 of them accomplished the VSCR/SFU DIPLOMA in HEALTH OUTCOME RESEARCH.

Students came from various countries: European Union, USA, Brazil, Mexico, South Korea, Middle East, Zambia, Kazakhstan, Ukraine, Russia, Nepal and Iran.  However, each of the module as before can be booked individually and qualify for a certificate issued by VSCR and SFU.

Learn more under https://vscr.at/en/public-health/

VSCR is proud to announce a strategic partnership with DIA EMEAIS in the field of copromotion of some of its courses, events and programs. This will bring synergies and added value for both organisations.

DIA is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow.

DIA is a non for profit membership association. It has a long and successful history in organising educational events and programs for the development and safe us of medicines. DIA EMEAIS organizes the next DIA Europe Annual Meeting in March 22^nd-24^th, 2023 in Basel, Switzerland

On 1 and 2 June 2022 VSCR will perform a GDPR (General data protection regulation) training for a health care organization in Dubai.

Many thanks to our Middle East business partner, Mohamed Fahmy, from Headway in Dubai. And to Mag. Nino Tlapak from DORDA attorney of law in Vienna who will give the lectures during these two days.

For more information about VSCR´s COURSES ON DEMAND, please contact office@vscr.at

LIEVEN ANNEMANS, renowned international health economist leads international diploma course HEALTH OUTCOME RESEARCH – MARKET ACCESS organized by the Vienna School of Clinical Research, Public Health and Medical Education (VSCR) together with the Sigmund Freud University Vienna (SFU). Over 20 participants will achieve a diploma this year.

Lieven Annemans, Senior Professor of Health Economics, University of Ghent, Belgium, is a sought-after and much-quoted international expert in the field of market access for medical innovations. He is an advisor to the Belgian government and many other health policy organizations and industry.

Lieven Annemans: “There is more than the drug budget” emphatically underlines the need for good HTA analyzes (Health Technology Assessment) in order to present the impact of new innovative drugs on the entire national health budget scientifically but also in a balanced manner for all stakeholders.

Lieven Annemans teaches the technology, acquisition and presentation of this data (“value dossier”) for such HTA analyzes, especially from the perspective of industry, in the joint online module course of the VSCR and the SFU.

The course modules have been taking place since 2018. This year, more than 20 participants will have successfully completed all three modules with a diploma.

Each of the modules can also be completed individually. The next module with Lieven Annemans will take place online on May 9th and 12th, 2022.

More at https://vscr.at/public-health/

VSCR provided from 7^th to 8^th February 2022 in cooperation with our business partner Mohamed Fahmy from Headway in Dubai and Dr. Heinrich Kühnert from DORDA Attorneys of law in Vienna an Anticompetition training for a health care organization in Dubai.

TOPIC: International Anticompetition and compliance regulations Pharma Industry

Speaker

Dr. Heinrich Kühnert, Attorney of Law from DORDA, Vienna: Antitrust law- a global view

Dr. Nicolas Bremer, Attorney of Law in Middle East: Antitrust law- local issues

Mag. Margarete Schreiner-Karner, VSCR: Anticompetitive behaviors- good promotional practices, EFPIA and SAUDI codes

Dubai towers

FROM OUTCOME DATA TO VALUE DOSSIERS: AN INTRODUCTION INTO THE BASICS OF SUCCESSFUL HTA SUBMISSIONS

Vienna School of Clinical Research, Public Health and Medical Education (VSCR) invites you to join us.

Some of the insights will be:

• Understand how payers assess technologies depending on their own incentives and setting;
• See the opportunities in changing payment systems for hospitals and clinicians;
• Have insights into the weaknesses of the QALY and the opportunities of disease specific outcome measures;
• Understand the need for a tailored yet coherent value story
• See the options about how to deal via agreements with uncertain evidence
• Understand why health economic evaluations need to start early in the development of medicines/health technologies
• Understand the need to align strategies across functional teams for successful market and patient access of new health technologies
• Have insights in how the development program can anticipate on value – based strategies and access

For more information and registration, go to www.vscr.at or contact office@vscr.at

The university course module “From Evidence to Health Outcome models” took place from 18-19 October 2021 as online/virtual training. Participants came from Middle East, Brazil, Mexico, Zambia and Europe. More than 15 countries were represented.

The first students who completed three modules had been awarded with university diploma jointly issued by VSCR and Sigmund Freud University Vienna.

In cooperation with the Medical Faculty of Sigmund Freud University of Vienna, the students are now awarded with a university certificate and after successful completion of three modules with a university diploma (“Health Outcome Research Diploma”).

Faculty: 

Dr. Jürgen Raths, Course director,  Geneva

Dr. Jörg Rustige, Germany

Dr. Steffen Wahler, Germany

For more information, plesae see link below

PR-TEXT_HEOR_October-DIPLOMA

Vienna School of Clinical Research, Public Health and Medical Education organizes next Market Access -ONLINE- TRAINING:

ADVANCED COURSE I will take place from 18-19 October 2021:

FROM CLINICAL EVIDENCE TO HTA – AN INTRODUCTION INTO THE BASICS OF HTA ASSESSMENTS

Deepening the knowledge & business case exercises

FACULTY:

Dr. Jürgen Raths, Managing Director Cordée Consulting, Geneva

Dr. Jörg Rustige, Germany

Dr. Steffen Wahler, Germany

NEUER HEALTH OUTCOME RESEARCH COURSE 7.-8. Juni 2021

 Vienna School of Clinical Research, Public Health and Medical Education organisierte neues Market Access -ONLINE- TRAINING:

BASISKURS vom 7. – 8. Juni 2021:

EVIDENCE BASED DECISION MAKING FOR PRICING AND REIMBURSEMENT: FROM THEORY TO PRACTICE

Vortragende:

Prof. Lieven Annemans, Senior Professor für Gesundheitsökonomie, Universität Gent, Belgien, ehemaliger Präsident ISPOR

Dr. Jürgen Raths, Geschäftsführer Cordée Consulting, Genf

Dr. Anna Bucsics, Projektberaterin bei MoCA (Mechanism of Coordinated Access to Orphan Medicinal Products)

Prof. Steven Simoens, Professor für Pharmakoökonomie – Universität Leuven, Belgien

Key NOTE LECTURE von Mag. Reneé. Gallo-Daniel, Präsident des Österreichischen Verbandes der Impfstoffhersteller (ÖVIH), Leiter Politik und Öffentlichkeitsarbeit Pfizer Corporation Austria

Die Teilnehmer kamen aus folgenden Ländern, Regionen: Brasilien, Mexiko, Großbritannien, Schottland, Deutschland, Bulgarien, Italien, Russland, Dubai, Israel, Kroatien, Ungarn, Naher Osten

Gruppen Foto Tag 1: Vortrag von Prof. Lieven Annemans

Gruppen Foto Tag 2: Vorträge von Dr. Jürgen Raths, Dr. Anna Bucsics, Prof. Steven Simoens, Mag. Reneé Gallo-Daniel

Vienna School of Clinical Research, Public Health and Medical Education is proud to announce its start of Advanced Diploma Program in Clinical Research for the whole staff of health ministry in Southeast Africa.

Lectures are given by:

Prof. Heinrich Klech (Austria): Introduction to Clinical Research/ Publication Master Class

Dr. Ingrid Klingmann (Belgium):Ethical aspects in clinical trials/  Introduction to Good Clinical Practice (GCP)/Clinical project management

Prof. Alexander Hönel (Austria): Regulatory approvals/authorization of clinical trials/  Inspections/audits of clinical trials

Prof. Bernd Minnich (Austria): Biomedical Statistics/ Advanced Biomedical Statistics

For more information please go to

https://vscr.at/clinical-research/vscr-diploma-in-clinical-research/

The Vienna School of Clinical Research, Public Health and Medical Education (VSCR) is proud to announce that its founder and managing director, Heinrich Klech MD, PhD, FACP recently has been awarded with the recognition and professional title

GLOBAL FELLOW IN MEDICINES DEVELOPMENT (GFMD)

by the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) and its IFFAP Academy in recognition of his significant contributions and achievements for the promotion of awareness and advancement of Pharmaceutical Medicine as a global discipline and profession.

Professor Heinrich Klech, apart from his international academic medical career as a specialist in pulmonary medicine, he made significant contributions for the science of Medicines Development and the Profession of  Pharmaceutical Medicine in his executive roles on the board of IMI-PHARMATRAIN  and EU-EMTRAIN  (both collaborative programs of the EU-Commission and EFPIA) over the past 12 years and later as a founding and  board member of the Pharmatrain Federation in Brussels. He led to a great extent the pathway for an international Master Program in Medicines Development and for establishing the professional degree “Specialist of Medicines Development” (SMD) at an international level.

The second VSCR-HTA online training took place from 21- 22 September 2020. Participants from the pharmaceutical industry and from universities took part in our virtual training.

The participants came from 15 different destinations: USA, Mexico, Dubai, Germany, India, Iran, Nepal, Great Britain, Scotland, Italy, France, Spain, Austria, Turkey, Switzerland.

The faculty made contributions from various locations – Vienna, Hamburg, Zurich.

Course directors were Dr. Jürgen Raths (Cordée Consulting) and Univ. Prof. Dr. Heinrich Klech (VSCR).

A special highlight was the joint elaboration of business cases in the context of virtual workshops with multicultural teams.

“I am very proud and happy that we were able to contribute to a multinational exchange of knowledge with new virtual media,” said Prof. Heinrich Klech, CEO VSCR.

From 13th to 14th December 2019, the VSCR organized a training session on the following topic in Nur-Sultan, Kazakhstan “Pharmacoeconomic Modeling Methods” for members of the Republican Center for Health Development of Ministry of Health in Nur-Sultan Kazakhstan. Read more…

The 3rd VSCR Science Summit Cardiovascular Medicine took place on 8 November 2019 at the newly opened “Hospital North-Clinic Floridsdorf”. Read more…

The international postgraduate ULG Health Outcome Research, co-hosted by VSCR and SFU, took place for the third time from 21.10.-23.10.2019 at the Sigmund Freud Private University. It included postgraduate students from Lithuania, Kazakhstan, Ukraine, Norway, the Czech Republic and Austria. Read more…

The international postgraduate ULG Health Outcome Research jointly organized by VSCR and SFU took place from 27-29 May 2019 at the Sigmund Freud University Vienna. There were postgraduate students from 20 different nations. Read more…

Vienna School of Clinical Research, Public Health and Medical Education (VSCR) participated at ISPOR Warsaw 2019 from 27–28 March 2019 and supported ISPOR Warsaw 2019 as exhibitor and with sponsorship. Read more…

The international postgraduate ULG Health Outcome Research jointly organized by VSCR and SFU took place from 15.11-18.11.18 at the Sigmund Freud University Vienna. Read more…

Vienna School of Clinical Research, Public Health and Medical Education (VSCR) participates at ISPOR Europe in Barcelona from 10–14 November 2018. Read more…

Vienna School of Clinical Research, Public Health and Medical Education (VSCR) participates at ISPOR Dubai 2018 from 19-20 September 2018. Read more…

Vienna School of Clinical Research, Public Health and Medical Education (VSCR) and Sigmund Freud University of Vienna (SFU) together will start with a new modular academic programme – Decision Making for Pricing and Reimbursement –from 15 to 18 November 2018 in Vienna. Read more…

Vascular diseases are significant common diseases and undoubtedly the most common cause of illness and death. Read more…

On 01 December 2018 the VSCR Science Summit Ophthalmology will take place for the second time under the chair of Univ.-Prof. Dr. Susanne Binder. Read more…

With the 2nd Science Summit Cardiology, organized by the Vienna School of Clinical Research (VSCR), a new congress series was successfully continued together with Gesellschaft der Ärzte in Vienna. In addition to providing basic information, the focus was on recent data and future trends. Renowned national and international experts presented and discussed the latest developments in cardiology.

“The medical knowledge in the field of cardiovascular medicine is developing with great speed, and it is impossible to critically examine all these innovations personally. With the 2nd VSCR Science Summit Cardiology on 27January 2018 in Vienna, we focus on the innovations of the most important cardiology areas. The aim is to present a practice-relevant update mediated by top experts. In addition to the basic lectures, case studies serve to deepen knowledge “, said Prim. Priv.-Doz. Dr. Georg Delle Karth.

Left to right: Binder, Wels; Delle-Karth; Vienna, presidency; Grabenwöger, Vienna, Klech, VSCR

On December 1st 2017 VSCR introduced for the first time its Science Summit in Opthalmology. Under the presidency of Prof. Susanne Binder, Sigmund Freud University Vienna, experts from Austria and Germany reported about latest scientific developments of the last 12 months. Additionally a lunch symposium gave more insight into latest developments about introcular multifocal  lens replacements.

Heinz Weber, incumbent chairman of the VSCR Educational Advisory Board will retire from his post of chairman. He was a great driver and supporter of the VSCR. It was his desire to serve on
this post not longer than 2 years. As an expert in cardiology he remains to be a member of the VSCR Board. The board of VSCR wants to thank Heinz Weber  very much for his dedication and efforts for the VSCR.
With great pleasure we want to announce that Prof. Andreas Festa, a reknown medical expert in diabetology from Medical University Vienna has accepted the position of chairman of the VSCR Educational Advisory Board. Prof Festa with his remarkable international career as diabetologist both in the fields of research as well as in continuing medical education will guarantee leadership and expertise for the VSCR Educational Advisory Board.

From the beginning all VSCR courses and events are characterized by a mandatory quality control whether the defined learning outcomes could be reached and the competence of the participants increased. Participants of the first 2 VSCR congresses had been requested to respond to specific questions about scientific subjects of the various presentations before and after the congress. It resulted in a mean increase of correct answers of 26% (with a range of  6 to 53%). This result demonstrate the importance to focus on learning outcomes. VSCR by virtue of its Quality Charter contributes to improvements  of standards in postgraduate education.  http://vscr.at/vscr-qualitaetsmanagement/

Under the leadership of Prof. Bernhard Ludvik and Prof. Gerhard Prager many international experts discussed current aspects and trends for therapeutic interventions. The risk of developing Diabetes by excessive overweight was a special focus and target of the conference. Technical and pragmatic aspects of bariatric surgery was another focus of the conference.

The VSCR management and board endorsed the use of enlarged and mandatory quality principles and measures for ALL VSCR courses and VSCR educational  events. Most attention will focus on the existence/development of defined learning objectives followed by  post-course-assessment of achieved learning outcomes of students or participants.  This will significantly contribute to the overall improvement of postgraduate learning and information. More information http://vscr.at/en/vscr-quality-management/